The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious Virus
Open accessAbstract
Metagenomics and a panmicrobial microarray were used to examine eight live-attenuated viral vaccines. Viral nucleic acids in trivalent oral poliovirus (OPV), rubella, measles, yellow fever, varicella-zoster, multivalent measles/mumps/rubella, and two rotavirus live vaccines were partially purified, randomly amplified, and pyrosequenced. Over half a million sequence reads were generated covering from 20 to 99% of the attenuated viral genomes at depths reaching up to 8,000 reads per nucleotides. Mutations and minority variants, relative to vaccine strains, not known to affect attenuation were detected in OPV, mumps virus, and varicella-zoster virus. The anticipated detection of endogenous retroviral sequences from the producer avian and primate cells was confirmed. Avian leukosis virus (ALV), previously shown to be noninfectious for humans, was present as RNA in viral particles, while simian retrovirus (SRV) was present as genetically defective DNA. Rotarix, an orally administered rotavirus vaccine, contained porcine circovirus-1 (PCV1), a highly prevalent nonpathogenic pig virus, which has not been shown to be infectious in humans. Hybridization of vaccine nucleic acids to a panmicrobial microarray confirmed the presence of endogenous retroviral and PCV1 nucleic acids. Deep sequencing and microarrays can therefore detect attenuated virus sequence changes, minority variants, and adventitious viruses and help maintain the current safety record of live-attenuated viral vaccines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As an example, gamma-irradiation of serum has been shown to be effective against a number of viruses 57 .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [57]
Citations
Cites
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Wang, C., Mitsuya, Y., Gharizadeh, B., Ronaghi, M., & Shafer, R. W. (2007) · Genome Research · doi:10.1101/gr.6468307 · Cited by 408
Self-citationLi, L., Kapoor, A., Slikas, B., Oderinde, B. S., Wang, C., Shaukat, S., Masroor, M. A., Wilson, M. L., Ndjango, J.-B. N., Peeters, M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02109-09 · Cited by 405
Self-citationMetagenomic Analyses of Viruses in Stool Samples from Children with Acute Flaccid Paralysis
Victoria, J. G., Kapoor, A., Li, L., Blinkova, O., Slikas, B., Wang, C., Naeem, A., Zaidi, S., & Delwart, E. (2009) · Journal of Virology · doi:10.1128/jvi.02301-08 · Cited by 376
Self-citationAllander, T., Emerson, S. U., Engle, R. E., Purcell, R. H., & Bukh, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211424698 · Cited by 374
Delwart, E. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.532 · Cited by 274
Self-citationA Serologic Follow-up of the 1942 Epidemic of Post-Vaccination Hepatitis in the United States Army
Seeff, L. B., Beebe, G. W., Hoofnagle, J. H., Norman, J. E., Buskell‐Bales, Z., Waggoner, J. G., Kaplowitz, N., Koff, R. S., Petrini, J. L., Schiff, E. R., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704163161601 · Cited by 250
Margeridon‐Thermet, S., Shulman, N. S., Ahmed, A., Shahriar, R., Liu, T. F., Wang, C., Holmes, S., Babrzadeh, F., Gharizadeh, B., Hanczaruk, B., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597808 · Cited by 205
Self-citationSome Biological and Physico‐Chemical Properties of Porcine Circovirus
Allan, G., Phenix, K. V., Todd, D., & McNulty, M. S. (1994) · Journal of Veterinary Medicine Series B · doi:10.1111/j.1439-0450.1994.tb00201.x · Cited by 105
Presence of antibodies reacting with porcine circovirus in sera of humans, mice, and cattle
Tischer, I., Bode, L., Apodaca, J., Timm, H., Peters, D., Rasch, R., Pociuli, S., & Gerike, E. (1995) · Archives of Virology · doi:10.1007/bf01322669 · Cited by 96
Cited by
Sorted by citations
Items 201–300 of 343
Chin, P.-J., Bhavsar, J., Bosma, T. J., MacDonald, M. L., Polson, S. W., & Khan, A. S. (2025) · mSphere · doi:10.1128/msphere.00286-25 · Cited by 8
Optimizing VLP production in gene therapy: Opportunities and challenges for in silico modeling
Zehetner, L., Széliová, D., Kraus, B., Graninger, M., Zanghellini, J., & Bort, J. A. H. (2023) · Biotechnology Journal · doi:10.1002/biot.202200636 · Cited by 8
Liang, Q., Tu, B., & Cui, L. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12939-w · Cited by 8
Bova, R. A., Diaz, L., Eubank, S., Overgard, A., Armstrong, A. A., & Hasson, B. (2024) · Biologicals · doi:10.1016/j.biologicals.2024.101771 · Cited by 8
SHAW, A. R. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-121511-093810 · Cited by 8
Högfeldt, T., Jaing, C. J., Loughlin, K. M., Thissen, J. B., Gardner, S. N., Bahnassy, A. A., Gharizadeh, B., Lundahl, J., Österborg, A., Porwit‐MacDonald, A., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.5012 · Cited by 8
Self-citationHan, H. H., Karkada, N., Jayadeva, G., & Dubin, G. O. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1231262 · Cited by 8
Johnson, E. S., Faramawi, M. F., Chedjieu, I. P., Delongchamp, R. R., Choi, K.-M., & Shen, T. (2018) · Environmental Research · doi:10.1016/j.envres.2018.07.037 · Cited by 8
Cell Culture-based Viral Vaccines: Current Status and Future Prospects
Zahoor, M. A., Khurshid, M., Qureshi, R., Naz, A., & Shahid, M. (2016) · Future Virology · doi:10.2217/fvl-2016-0006 · Cited by 9
Sheets, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.023 · Cited by 7
Deng, Y., Cai, W., Li, J., Li, Y., Yang, X., Ma, Y., Yao, Y., Yang, L., Shi, L., & Sun, M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.11.020 · Cited by 7
Wang, C., Pang, V. F., Jeng, C., Lee, F., Huang, Y.-W., Lin, Y.-L., Hsiao, S.-H., & Lai, S. S. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0072-7 · Cited by 7
Self-citationBao, R., Shibuya, A., Uehira, T., Sato, T., Urayama, T., Sakai, K., & Yunoki, M. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.10.006 · Cited by 7
Regulatory considerations for raw materials used in biological products.
Khan, A. S. (2010) · PubMed · Cited by 7
Cell Culture–Derived Influenza Vaccines: Has Their Time Come?
Bernstein, D. I. (2010) · Clinical Infectious Diseases · doi:10.1086/656583 · Cited by 7
Fukumoto, H., Hishima, T., Hasegawa, H., Saeki, H., Kuroda, M., & Katano, H. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.031 · Cited by 6
Laboratory Methods in Molecular Epidemiology: Viral Infections
Parreira, R. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.ame-0003-2018 · Cited by 6
Frese, L., Darwiche, S., Gunning, M., Hoerstrup, S. P., von Rechenberg, B., Giovanoli, P., & Calcagni, M. (2022) · Health Science Reports · doi:10.1002/hsr2.449 · Cited by 6
Shimode, S., Sakuma, T., Yamamoto, T., & Miyazawa, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-10497-1 · Cited by 6
Dore, D. D., Turnbull, B., & Seeger, J. D. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3217 · Cited by 6
Massively Parallel Sequencing for the Detection of Adventitious Viruses
Kolman, J. L. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00836 · Cited by 6
Antiviral Pathogenesis and Interventions: New Understandings and Developments
PATIL, A. R., Singh, N., & Bange, K. (2023) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2023.06.1278 · Cited by 6
Deisher, T. A., Doan, N. V., Koyama, K., & Bwabye, S. (2015) · PubMed · Cited by 6
Large-Scale Sequencing and the Natural History of Model Human RNA Viruses
Dugan, V. G., Saira, K., & Ghedin, E. (2012) · Future Virology · doi:10.2217/fvl.12.45 · Cited by 6
Pharmacoepidemiologic Studies of Vaccine Safety
Chen, R. T., Glanz, J. M., & Vellozzi, C. J. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch26 · Cited by 6
Adventitious Viral Contamination of Biopharmaceuticals: Who is at Risk?
Nims, R. W. (2011) · BioProcessing Journal · doi:10.12665/j101.nims · Cited by 5
Regulatory Approaches for Control of Viral Contamination of Vaccines
McClenahan, S. D., Uhlenhaut, C., & Krause, P. R. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00819 · Cited by 5
Gabriel, M. A., Dare, E. V., Meunier, S. M., Campbell, J. L., Sasges, M. R., & Aucoin, M. G. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.063 · Cited by 5
Tombácz, K., Patterson, R., Grierson, S. S., & Werling, D. (2014) · Genome Announcements · doi:10.1128/genomea.00156-14 · Cited by 5
Veerasami, M. (2014) · Journal of Veterinary Science & Technology · doi:10.4172/2157-7579.1000179 · Cited by 6
Viral safety for biotherapeutics and biosimilar
Ruppach, H. (2020) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2020.08.001 · Cited by 5
Bačnik, K., Kutnjak, D., Kokelj, B. J., Tuta, N., Lončar, T., Vogelsang, M., & Ravnikar, M. (2020) · Biologicals · doi:10.1016/j.biologicals.2020.11.001 · Cited by 5
Next-Generation Sequencing as Diagnostic Tool in Veterinary Research
Kumar, D. (2019) · Journal of animal research · doi:10.30954/2277-940x.06.2019.1 · Cited by 5
Yen, C., & Cortese, M. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00216-4 · Cited by 5
Design of genomic signatures for pathogen identification and characterization
Slezak, T., Hart, B. R., & Jaing, C. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815379-6.00020-9 · Cited by 5
Self-citationScreening of Viral Pathogens from Pediatric Ileal Tissue Samples after Vaccination
Hewitson, L. C., Thissen, J. B., Gardner, S. N., McLoughlin, K., Glausser, M. K., & Jaing, C. J. (2014) · Advances in Virology · doi:10.1155/2014/720585 · Cited by 5
Self-citationImpact of environmental factors on the prevalence of autistic disorder after 1979
Theresa, A. D., Ngoc, V. D., Angelica, O., Kumiko, K., & Bwabye, S. (2014) · Journal of Public Health and Epidemiology · doi:10.5897/jphe2014.0649 · Cited by 5
Parashar, U. D., Cortese, M. M., & Offit, P. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00051-1 · Cited by 5
Chapter Two: Literature Review
Shbikat, N. (2021) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783957102980-22 · Cited by 5
Khan, A. S., Mallet, L., Blümel, J., Deneyer, N., Keersmaecker, S. C. J. D., de Saint-Vis, B., Knežević, I., Logvinoff, C., Murphy, M., Ng, S. H. S., et al. (2025) · Biologicals · doi:10.1016/j.biologicals.2025.101859 · Cited by 4
Communicating computational workflows in a regulatory environment
Keeney, J., Gulzar, N., Baker, J. B., Klempíř, O., Hannigan, G. D., Bitton, D. A., Maritz, J. M., King, C. H. S., Patel, J. A., Duncan, P. A., et al. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103884 · Cited by 4
Houspie, L., Keyaerts, E., Maes, P., & Ranst, M. A. V. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.01.008 · Cited by 4
Yang, B., Wang, H., Kaleas, K. A., Butler, M., Franklin, J., Bill, A., Baylis, S. A., Chen, Q., & Blümel, J. (2020) · Biotechnology Progress · doi:10.1002/btpr.2968 · Cited by 4
Ma, H., Bosma, T. J., & Khan, A. S. (2023) · Viruses · doi:10.3390/v15101998 · Cited by 4
Live Attenuated Viral Vaccines
Galinski, M. S., Sra, K., Haynes, J. I., & Naspinski, J. (2014) · Springer eBooks · doi:10.1007/978-3-662-45024-6_1 · Cited by 4
Nawab, D. H. (2015) · Journal of Next Generation Sequencing & Applications · doi:10.4172/2469-9853.1000116 · Cited by 4
Yu, Q., Liu, Y., Du, J., Liu, Y., Zhang, L., & Guo, T. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000875 · Cited by 4
Pharmacoepidemiologic Studies of Vaccine Safety
Chen, R. T., Glanz, J. M., & Shimabukuro, T. T. (2019) · Pharmacoepidemiology · doi:10.1002/9781119413431.ch20 · Cited by 4
IABS/DCVMN webinar on next generation sequencing
Khan, A. S., Theuns, S., Mallet, L., Cirefice, G., Bhuller, R. K., Goios, A., Suri, R. K., & Neels, P. (2022) · Biologicals · doi:10.1016/j.biologicals.2022.12.001 · Cited by 3
Modified human skin cell isolation protocol and its influence on keratinocyte and melanocyte culture
Liu, Z., Jin, S., Cheng, D., Chen, H., Wang, Y., Ji, C., Yan, Z., Fang, X., Xiao, S., & Bi, X. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.05.014 · Cited by 3
Alston, A., Bova, R. A., & Hasson, B. (2025) · Biologicals · doi:10.1016/j.biologicals.2025.101828 · Cited by 3
Clark, H. F., Offit, P. A., & Parashar, U. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00037-9 · Cited by 3
Gröner, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100623-8.00049-9 · Cited by 3
Standards and Metrology for Viral Vectors as Molecular Tools: Outcomes from a CCQM Workshop
Campbell, J. J., Almond, N. M., Bae, Y.-K., Bhuller, R. K., Briones, A., Cho, S., Cleveland, M. H., Cleveland, T. E., Galaway, F., He, H., et al. (2024) · Biologics · doi:10.3390/biologics4020013 · Cited by 3
Yangın, S., Tanman, Ü., & Cansaran‐Duman, D. (2019) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2019.33576 · Cited by 3
Regulatory and Biosafety Challenges for Vaccines
Nafian, F., Nafian, S., & Azad, B. K. D. (2020) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.14.1.17 · Cited by 3
Deep Sequencing Applications for Vaccine Development and Safety
Onions, D. E., Cote, C. A., Love, B., & Kolman, J. L. (2014) · Springer eBooks · doi:10.1007/978-3-662-45024-6_11 · Cited by 3
Vaccinology Is Turning into an Omics‐Based Science
Prachi, P., Biagini, M., & Bagnoli, F. (2012) · Drug Development Research · doi:10.1002/ddr.21048 · Cited by 4
Furtak, V. A., Dabrazhynetskaya, A., Volokhov, D. V., & Chizhikov, V. E. (2014) · Biologicals · doi:10.1016/j.biologicals.2014.10.005 · Cited by 3
Naked PCV-2 cloned genomic DNA is infectious by mucosal (intratracheal or oro-nasal) inoculation
Grasland, B., Bigault, L., Corvec, M. L., Hernandez-Nignol, A.-C., Oger, A., Dory, D., Rose, N., Cariolet, R., & Jestin, A. (2012) · Virus Research · doi:10.1016/j.virusres.2012.01.006 · Cited by 3
Use of DOP-PCR in Non-Specific Virus Detection
Uhlenhaut, C., McClenahan, S. D., & Krause, P. R. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00842 · Cited by 3
Virus Risk Mitigation for Raw Materials
Wisher, M. H. (2013) · Cited by 3
Mucosal Immunization Using Polyester-Based Particulate Systems
Gaspar, D. P., Peres, C., Florindo, H. F., & Almeida, A. J. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-17 · Cited by 3
Role of Analytics in Viral Safety
Sheets, R., & Duncan, P. A. (2014) · Springer eBooks · doi:10.1007/978-3-662-45024-6_10 · Cited by 3
Strong, M. J., Lin, Z. N., & Flemington, E. K. (2014) · mBio · doi:10.1128/mbio.01989-14 · Cited by 3
Swayne, D. E. (2013) · Wiley eBooks · doi:10.1002/9781119421481.ch15 · Cited by 3
Improving Food Safety in Africa Using Cutting-Edge Biotechnology & Molecular Biology Approaches
Alhassan, Y., Ajadi, A. O., Oni, G. J., Wurie, A. W., & Olajide, T. E. (2024) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2024/v16i9403 · Cited by 2
Risk of Mortality From Esophageal Cancer Among US Poultry Workers, 1950−2019
Delhey, L. M., Joshua, C., Allen, J. L., Delongchamp, R. R., Amick, B. C., & Nembhard, W. N. (2025) · American Journal of Industrial Medicine · doi:10.1002/ajim.23742 · Cited by 2
Rotavirus Vaccines and Vaccination
Vesikari, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802241-2.00015-8 · Cited by 2
Real-time quantitative PCR assay for rapid detection of murine virus contamination in bioproducts
Guo, L., Zhang, Z., Gong, R., & Xiao, G. (2014) · Virologica Sinica · doi:10.1007/s12250-014-3449-3 · Cited by 2
Tate, J. E., Cortese, M. M., Offit, P. A., & Parashar, U. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00053-0 · Cited by 2
Parallel Evaluation of Broad Virus Detection Methods
Modrof, J., Berting, A., & Kreil, T. R. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.01014 · Cited by 2
Meeting Report: PDA Virus and TSE Safety Forum
Willkommen, H., Blümel, J., Brorson, K., Chen, D. A., Chen, Q., Gröner, A., Kreil, T. R., Robertson, J. S., Ruffing, M., & Ruiz, S. (2013) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2013.00906 · Cited by 2
“Virus hunting” using radial distance weighted discrimination
Xiong, J., Dittmer, D. P., & Marron, J. S. (2015) · The Annals of Applied Statistics · doi:10.1214/15-aoas869 · Cited by 2
Overview of Emerging Technologies To Detect Adventitious Agents
Onions, D. E. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00834 · Cited by 2
Feng, S. F., Jaing, C. J., Thissen, J. B., Wang, C., & Duncan, P. A. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.01011 · Cited by 2
Self-citationLindholm, M., Jørgensen, L. L., Blixenkrone-Møller, M., Sandberg, E. W., Frandsen, P. L., Østergaard, E., Bækdahl, E. R., Fridholm, H., Fomsgaard, A., & Rosenstierne, M. W. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.10.005 · Cited by 2
Meeting Report: 2013 PDA Virus & TSE Safety Forum
Willkommen, H., Blümel, J., Brorson, K., Chen, D. A., Chen, Q., Gröner, A., Hubbard, B. R., Kreil, T. R., Ruffing, M., Ruiz, S., et al. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.00980 · Cited by 2
Efficient extraction of adventitious virus nucleic acid using commercially available methods
Valiant, W. G., Borman, J., Cai, K., & Vallone, P. M. (2023) · Biologicals · doi:10.1016/j.biologicals.2023.101741 · Cited by 2
Kroger, A. T., Mawle, A. C., Pickering, L. K., & Orenstein, W. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00006-4 · Cited by 2
Sousa, A. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.34.005501 · Cited by 2
The hidden threat of unidentified agents of disease in human and veterinary biologicals
Chiu, C. Y. (2013) · Biologicals · doi:10.1016/j.biologicals.2013.03.004 · Cited by 2
Evolving Needs For Viral Safety Strategies in Continuous Monoclonal Antibody Bioproduction
Clutterbuck, A., Cunningham, M. A., Geyer, C., Genest, P., Bourguignat, M., & Berg, H. (2017) · Wiley eBooks · doi:10.1002/9783527699902.ch11 · Cited by 2
Kjemtrup, S., Talarico, T. L., & Ursin, V. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-52512-3.00215-1 · Cited by 2
Viviani, L., Vandeputte, J., Smith, D., Coppens, E., Mahmood, K., Goel, S. K., Wenzel, E. V., Sun, L., Milne, C., Meyer, Q. C., et al. (2025) · Biologicals · doi:10.1016/j.biologicals.2025.101821 · Cited by 1
Promising Vaccine Formulations for Emerging Infectious Diseases
Park, P., Lee, S.-Y., Youn, H., & Hong, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104893 · Cited by 1
Chin, P.-J., Tsou, J.-H., Armstrong, A. A., Deneyer, N., Zanda, V. M., Ayama-Canden, S., Colinet, A.-S., Fuentes, S. M., Korokhov, N., Lambert, C., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01351-2 · Cited by 1
Bachtarzi, H. (2022) · Regenerative Medicine · doi:10.2217/rme-2021-0177 · Cited by 1
Tsinda, E. K., Swofford, C. A., Strutt, J. P. B., Sangerman, J., Roushangar, R., Li, A., Gomez, L. M., Bousquet, A. N., Neufeld, C. I., Wolfrum, J. M., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101478 · Cited by 1
van der Kuyl, A. C. (2026) · Pathogens · doi:10.3390/pathogens15010104 · Cited by 1
Design of Genomic Signatures for Pathogen Identification and Characterization
Slezak, T., Gardner, S. N., Allen, J., Vitalis, E. A., Torres, M. W., Torres, C., & Jaing, C. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-382006-8.00029-3 · Cited by 1
Self-citationTheory and Practice of Conventional Adventitious Virus Testing
Gregersen, J. P. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00832 · Cited by 1
McClenahan, S. D., & Krause, P. R. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.01030 · Cited by 1
Session 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies
Bakhshayeshi, M., & Specht, R. (2016) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2016.006965 · Cited by 1
Анатольевна, Е. М., Mukhamedzhanova, A., Mahmud, R. S., Khammadov, N. I., Валерьевич, У. К., Nesterova, I. A., Фаизов, Т. Х., & Ilinskaya, O. N. (2021) · BioNanoScience · doi:10.1007/s12668-021-00862-1 · Cited by 1
Dormitzer, P. R. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00152-1 · Cited by 1
Cortese, M. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00216-0 · Cited by 1
Mousavi, S. M. R.-N., Hosseini, S. M., & Ansari, S. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i5.13877 · Cited by 1
Vacunas antirrotavirus. Un largo y difícil camino
Campins, M., & Llop, F. A. M. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2011.09.003 · Cited by 1
A Novel Cell Substrate Candidate for Rabies Virus Vaccine Propagation and Production
Fazeli, M. R. (2015) · International Journal of Vaccines & Vaccination · doi:10.15406/ijvv.2015.01.00013 · Cited by 1
Metadata
- Authors
- Victoria, J. G., Wang, C., Jones, M. S., Jaing, C., McLoughlin, K., Gardner, S., & Delwart, E. L.
- Affiliations
- University of California, San Francisco (US)
- Stanford University (US)
- David Grant USAF Medical Center (US)
- Lawrence Livermore National Laboratory (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2010-06-15
- Volume
- 84
- Issue
- 12
- Pages
- 6033-6040
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2876658
- OpenAlex
- W2106638291
- Cited by
- 342
- References
- 38
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 8 · 2023: 10 · 2022: 10 · 2021: 13 · 2020: 17 · 2019: 17 · 2018: 22 · 2017: 18 · 2016: 25 · 2015: 19 · 2014: 48 · 2013: 29 · 2012: 23
- FWCI
- 27.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy (DEAC5207NA27344, AC52‐07NA27344)
- Blood Systems Research Institute (R01HL083254)
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- U.S. Air Force
- National Heart, Lung, and Blood Institute (R01HL083254)
- Air Force Surgeon General
- Lawrence Livermore National Laboratory (DE‐AC5207NA27344, 02-SI-008, AC52-07NA27344)
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- live attenuated vaccine, viral nucleic acids, minority variants, adventitious viruses, oral polio vaccine, rubella vaccine, measles vaccine, yellow fever vaccine, varicella-zoster vaccine, mumps vaccine, rotavirus vaccine, Rotarix, porcine circovirus type 1, endogenous retroviruses, avian leukosis virus, simian retroviruses, vaccine safety, metagenomics
- MeSH terms
- Animals, DNA, Viral, Humans, Molecular Sequence Data, Phylogeny, Vaccines, Attenuated, Genetic Variation, Viral Vaccines, Virus Diseases, Viruses, Genome, Viral, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review